Skip to main content
Back to Lightspeed Venture Partners

Lightspeed Venture Partners's Biotechnology Portfolio

Browse 3 Biotechnology companies funded by Lightspeed Venture Partners. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
3
Total Funding in Biotechnology
$458.0M

Biotechnology Portfolio Companies (3)

Export
BiotechnologyHealth CareOncologyTherapeutics

Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.

Boston, United States
May 2026
$213.0M
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyMedicalNeuroscience

Science is a clinical-stage medical technology company that develops neuroengineering systems to address neurological and sensory disorders.

Alameda, United States
March 2026
$230.0M
Series C

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyHealth CareTherapeutics

Enlaza Therapeutics is a biotechnology research company.

La Jolla, United States
September 2025
$15.0M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

Explore Lightspeed Venture Partners's Full Portfolio

View all companies funded by Lightspeed Venture Partners across every industry and funding stage.

View Full Lightspeed Venture Partners Portfolio